compound 33

BoNT-IN-33 is a potent inhibitor of Botulinum neurotoxin A light chain (BoNT A LC).

Compound 2222-33-5, with CAS No. 2222-33-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 2222-33-5 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 32863-33-5, with CAS No. 32863-33-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 32863-33-5 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 76532-33-7, with CAS No. 76532-33-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 76532-33-7 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 33282-21-2, with CAS No. 33282-21-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 33282-21-2 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 337536-15-9, with CAS No. 337536-15-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 337536-15-9 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

3344 is an inhibitor of KRAS-effector interactions,with an affnity of 126nm.

Compound 3344 hydrochloride is an inhibitor of KRAS-effector interactions,with an affnity of 126nM.

Compound Fr12413, with CAS No. 18851-33-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12413 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12778, with CAS No. 465514-33-4, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12778 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13698, with CAS No. 529-33-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13698 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14048, with CAS No. 6705-33-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14048 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14081, with CAS No. 622-33-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14081 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14184, with CAS No. 13220-33-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14184 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14304, with CAS No. 5437-33-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14304 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14309, with CAS No. 369-33-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14309 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14510, with CAS No. 2713-33-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14510 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr16642, with CAS No. 16874-33-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr16642 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr16720, with CAS No. 108-33-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr16720 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound PDK0406, with CAS No. 930-33-6, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0406 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12109, with CAS No. 15029-33-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12109 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12574, with CAS No. 780802-33-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12574 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12610, with CAS No. 183210-33-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12610 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12832, with CAS No. 270260-33-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12832 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.